Walleye Trading’s 89bio ETNB Stock Holding History

Walleye Trading’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,900	Closed	-$86.7K	–	4459
2025 Q3	$86.7K	Sell	5,900 -4,500	-43%	-$45.9K	﹤0.01%	3775
2025 Q2	$102K	Buy	+10,400	New	+$86.1K	﹤0.01%	3584
2024 Q1	–	Sell	-52,300	Closed	-$584K	–	4917
2023 Q4	$584K	Sell	52,300 -1,200	-2%	-$11K	﹤0.01%	2943
2023 Q3	$826K	Buy	53,500 +50,500	+1,683%	+$848K	﹤0.01%	2531
2023 Q2	$56.9K	Buy	+3,000	New	+$52.7K	﹤0.01%	3928
2023 Q1	–	Sell	-9,100	Closed	-$116K	–	4968
2022 Q4	$116K	Buy	+9,100	New	+$81.9K	﹤0.01%	3899

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Trading's ETNB Position: Q4 2025 in Review

Walleye Trading sold out of 89bio (ETNB) in Q4 2025, closing a stake of 8,816 shares — an estimated $130K sold.

Walleye Trading first reported a position in ETNB in Q3 2022 and held it in 8 quarters. The position peaked at $789K in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Walleye Trading reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Walleye Trading sold 8,816 89bio shares in Q4 2025, an estimated $130K.
Walleye Trading first reported a position in 89bio in Q3 2022 and held it in 8 quarters.
Walleye Trading's 89bio position peaked at $789K in Q4 2022.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.